SCHEMBL22828271

SCHEMBL22828271

CN1CCN(c2ccc(Nc3nc(Nc4ccccc4N)c4occc4n3)cc2)CC1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CCNK O75909 2/20 0.52
CCNA2 P20248 2/20 0.52
CDK2 P24941 2/20 0.52
CCND3 P30281 2/20 0.52
CDK9 P50750 2/20 0.52
CDK6 Q00534 2/20 0.52
BTK Q06187 2/20 0.50
JAK3 P52333 1/20 0.50
CD69 Q07108 1/20 0.50
ALK Q9UM73 2/20 0.48
BRD4 O60885 3/20 0.47
BRD2 P25440 2/20 0.47
BRD3 Q15059 2/20 0.47
ADRA2A P08913 4/20 0.47
ADRA2B P18089 4/20 0.47
ADRA2C P18825 4/20 0.47
SLC2A1 P11166 2/20 0.47
KDM1A O60341 1/20 0.47
GLA P06280 1/20 0.47
RECQL P46063 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22807426 0.83 SRC (0.68) BTKJAK3CD69FLT3MAP3K7
SCHEMBL22807398 0.82 IRAK4 (0.60) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL22807405 0.78 BRD4 (0.59) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL29549396 0.77 CCND3 (0.63) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL22807437 0.77 EGFR (0.65) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL22828249 0.77 CCNK (0.63) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL22807421 0.77 CCND3 (0.63) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL29549413 0.77 EGFR (0.65) CCNKCCNA2CDK2CCND3CDK9
SCHEMBL22807397 0.75 BTK (0.62) BTKJAK3CD69ADRA2AFLT3
SCHEMBL22828273 0.75 CCNK (0.60) CCNKCCNA2CDK2CCND3CDK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020257385-A1 SMALL MOLECULE INHIBITORS OF SRC TYROSINE KINASE DANA-FARBER CANCER INSTITUTE, INC. (US) 2020-12-24 WO disclosed